United States · 
Who invested in Slate Medicines?
Slate Medicines's investors include RA Capital Management, Forbion Capital Partners and Foresite Capital.
United States · Series A startup
Who invested in Slate Medicines
Funding summaryUpdated 26 Oct 2026
$130Mraised across 1 round since 2026, from 1 source
- Latest round
- Series A, $130MFeb 2026
- Investors
- 3
The rounds
- Feb 2026Series A$130M
Source recordedSEC filing: $10.0M sold, first sale Feb 2026
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Slate Medicines
How much has Slate Medicines raised?
Slate Medicines has raised $130M across 1 round since 2026.
When did Slate Medicines last raise?
Slate Medicines's most recent round was a Series A of $130M in Feb 2026.
What was Slate Medicines's biggest round?
Its most recent round, $130M in Feb 2026, is also its largest on record.
Who backed Slate Medicines first?
Slate Medicines's first round on record, in Feb 2026, was backed by RA Capital Management, Forbion Capital Partners and Foresite Capital.
What stage is Slate Medicines at?
Slate Medicines's latest named round is a Series A, in Feb 2026.
Where is Slate Medicines based?
Slate Medicines is based in the United States.
Companies like Slate Medicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.